Treatment for acute myeloid leukemia M5, or acute monocytic leukemia, consists mainly of chemotherapy and hematopoietic stem cell transplantation. Acute mononuclear cell leukemia treatment is the same as acute myeloid leukemia (AML). 1. Induced remission treatment: the purpose of treatment is to restore the hematopoietic function of bone marrow as soon as possible, and the most commonly used induced remission program is “3+7” program: on the 1st~3rd day, Zoerythromycin is injected intravenously, and on the 1st~7th day, cytarabine is injected intravenously continuously, 60%~80% of the patients can achieve complete remission. 2. Post-remission treatment: The aim of treatment is to strive for long-term disease-free survival and cure. There are three options for post-remission treatment: consolidation chemotherapy, allogeneic or autologous stem cell transplantation. Drugs include cytarabine, etc. In addition, for recurrent AML, as well as AML in the elderly also need to choose the appropriate treatment according to the specific circumstances, such as to be Vinaclat combined with azacitidine, etc. Therefore, if the diagnosis of AML should be standardized treatment as soon as possible, and under the guidance of specialists to choose the appropriate treatment.